[1] |
Miao Y, Zhao Y, Han L, et al. Nsun2 regulates aneurysm formation by promoting autotaxin expression and t cell recruitment[J]. Cell Mol Life Sci, 2021, 78: 1709-1727. doi: 10.1007/s00018-020-03607-7
|
[2] |
Gemmete JJ, Toma AK, Davagnanam I, et al. Pediatric cerebral aneurysms[J]. Neuroimaging Clin N Am, 2013, 23: 771-779. doi: 10.1016/j.nic.2013.03.018
|
[3] |
Guerrero WR, Dandapat S, Ortega-Gutierrez S. Hemorr-hagic cerebrovascular pathology in the pediatric population[J]. Front Neurol, 2020, 11: 1055. doi: 10.3389/fneur.2020.01055
|
[4] |
Kim ST, Brinjikji W, Lanzino G, et al. Neurovascular manifestations of connective-tissue diseases: a review[J]. Interv Neuroradiol, 2016, 22: 624-637. doi: 10.1177/1591019916659262
|
[5] |
中华医学会儿科学分会风湿病学组, 中国医师协会风湿免疫科医师分会儿科学组, 海峡两岸医药卫生交流协会风湿免疫病学专业委员会儿童学组, 等. 儿童自身炎症性疾病诊断与治疗专家共识[J]. 中华实用儿科临床杂志, 2022, 37: 161-172. doi: 10.3760/cma.j.cn101070-20211109-01333
|
[6] |
沈敏, 青玉凤, 史晓飞, 等. 自身炎症性疾病诊断规范[J]. 中华内科杂志, 2021, 60: 1129-1138. doi: 10.3760/cma.j.cn112138-20210611-00415
|
[7] |
Zhou Q, Yang D, Ombrello AK, et al. Early-onset stroke and vasculopathy associated with mutations in ada2[J]. N Engl J Med, 2014, 370: 911-920. doi: 10.1056/NEJMoa1307361
|
[8] |
Crow YJ. Type i interferonopathies: A novel set of inborn errors of immunity[J]. Ann N Y Acad Sci, 2011, 1238: 91-98. doi: 10.1111/j.1749-6632.2011.06220.x
|
[9] |
Crow YJ, Manel N. Aicardi-goutieres syndrome and the type i interferonopathies[J]. Nat Rev Immunol, 2015, 15: 429-440. doi: 10.1038/nri3850
|
[10] |
Ramesh V, Bernardi B, Stafa A, et al. Intracerebral large artery disease in aicardi-goutieres syndrome implicates samhd1 in vascular homeostasis[J]. Dev Med Child Neurol, 2010, 52: 725-732. doi: 10.1111/j.1469-8749.2010.03727.x
|
[11] |
Xin B, Jones S, Puffenberger EG, et al. Homozygous mutation in samhd1 gene causes cerebral vasculopathy and early onset stroke[J]. Proc Natl Acad Sci USA, 2011, 108: 5372-5377. doi: 10.1073/pnas.1014265108
|
[12] |
Sanchez GAM, Reinhardt A, Ramsey S, et al. Jak1/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies[J]. J Clin Invest, 2018, 128: 3041-3052. doi: 10.1172/JCI98814
|
[13] |
Seo J, Kang JA, Suh DI, et al. Tofacitinib relieves symptoms of stimulator of interferon genes (sting)-associ-ated vasculopathy with onset in infancy caused by 2 de novo variants in tmem173[J]. J Allergy Clin Immunol, 2017, 139: 1396-1399. e1312. doi: 10.1016/j.jaci.2016.10.030
|